The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Terlipressin in acute oesophageal variceal haemorrhage
Abstract
Summary: Background : Controversy exists surrounding pharmacological therapy in acute variceal bleeding. Aim : To determine the efficacy and safety of terlipressin. Methods : Randomized trials were identified and duplicate, independent, review identified 20 randomized trials involving 1609 patients that compared terlipressin with placebo, balloon tamponade, endoscopic treatment, octreotide, somatostatin or vasopressin for treatment of acute oesophageal variceal haemorrhage. Results : Meta‐analysis showed that compared to placebo, terlipressin reduced mortality (relative risk 0.66, 95% CI 0.49–0.88), failure of haemostasis (relative risk 0.63, 95% CI 0.45–0.89) and the number of emergency procedures per patient required for uncontrolled bleeding or rebleeding (relative risk 0.72, 95% CI 0.55–0.93). When used as an adjuvant to endoscopic sclerotherapy, terlipressin reduced failure of haemostasis (relative risk 0.75, 95% CI 0.58–0.96), and had an effect on reducing mortality that approached statistical significance (relative risk 0.74, 95% CI 0.53–1.04). No significant difference was demonstrated between terlipressin and endoscopic sclerotherapy, balloon tamponade, somatostatin or vasopressin. Haemostasis was achieved more frequently with octreotide compared to terlipressin (relative risk 1.62, 95% CI 1.05–2.50), but this result was based on unblinded studies. Adverse events were similar between terlipressin and the other comparison groups except for vasopressin, which caused more withdrawals due to adverse events. Conclusions : Terlipressin is a safe and effective treatment for acute oesophageal variceal bleeding, with or without adjuvant endoscopic sclerotherapy. Terlipressin appears to reduce mortality in acute oesophageal variceal bleeding compared to placebo, and is the only pharmacological agent shown to do so. Future studies will be required to detect potential mortality differences between terlipressin and other therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Cited by
Sanyal, A. J., Boyer, T., Garcia–Tsao, G., Regenstein, F., Rossaro, L., Appenrodt, B., Blei, A., Gülberg, V., Sigal, S., & Teuber, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.014 · Cited by 663
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
The management of portal hypertension: Rational basis, available treatments and future options
Bosch, J., Berzigotti, A., Garcia-Pagan, J. C., & Abraldes, J. G. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.021 · Cited by 319
Terlipressin for acute esophageal variceal hemorrhage
Ioannou, G. N., Doust, J., & Rockey, D. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002147 · Cited by 254
Self-citationMull, R. W., Harrington, A., Sanchez, L. A., & Tal-Gan, Y. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180518090705 · Cited by 41
Metadata
- Authors
- Ioannou, G. N., Doust, J., & Rockey, D. C.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2002-12-19
- Volume
- 17
- Issue
- 1
- Pages
- 53-64
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2071690367
- Cited by
- 185
- References
- 2
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Terlipressin in acute oesophageal variceal haemorrhage. https://app.cochat.ai/papers/10.1046/j.1365-2036.2003.01356.x
- The paper
- Ioannou, G. N., Doust, J., & Rockey, D. C. (2003). Terlipressin in acute oesophageal variceal haemorrhage. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2003.01356.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.